Adverse events (GI) · obese women with subfertility
It is very uncertain whether pharmacological intervention changes adverse events (GI) compared with no intervention or placebo (very low certainty).
1 finding from 1 review
Clinical pregnancy · obese women with subfertility
It is very uncertain whether pharmacological intervention changes clinical pregnancy compared with no intervention or placebo (very low certainty).
1 finding from 1 review
Weight changeBMI WHR · obese women with subfertility
1 finding from 1 review
Quality of life/Mental health outcome · obese women with subfertility
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Depression: meeting study criteria for depression at end of · people with depression after stroke
2 findings from 1 review
Depression: < 50% reduction in scale scores at end of treatment (primary outcome) · people with depression after stroke
1 finding from 1 review
Depression: mean scores at end of treatment (secondary outcome) · people with depression after stroke
1 finding from 1 review
Adverse events: death ‐ at end of treatment (secondary outcome) · people with depression after stroke
1 finding from 1 review
Gastrointestinal adverse events · people with depression after stroke
1 finding from 1 review
Return to work · cancer patients
Physical interventions probably leads to higher RTW compared with care (moderate certainty).
1 finding from 1 review
QoL · cancer patients
1 finding from 1 review
Body‐mass index (BMI) · children aged 5 to 11 years
2 findings from 1 review
zBMI short term (12 weeks from baseline to < 9 months) · children aged 5 to 11 years
1 finding from 1 review
zBMI medium term (9 months to < 15 months) · children aged 5 to 11 years
1 finding from 1 review
zBMI long term (> 15 months) · children aged 5 to 11 years
1 finding from 1 review
Serious adverse events · children aged 5 to 11 years
1 finding from 1 review
BMI short‐term (12 weeks from baseline to < 9 months) · children aged 5 to 11 years
1 finding from 1 review
Body‐mass index (BMI) · children aged 12 to 18 years
3 findings from 1 review
no estimate extracted
1 study · 985 participants
Low
no estimate extracted
6 studies · 1780 participants
Low
no estimate extracted
3 studies · 2143 participants
Low
zBMI short term (12 weeks from baseline to < 9 months) · children aged 12 to 18 years
1 finding from 1 review
zBMI medium term (9 months to < 15 months) · children aged 12 to 18 years
1 finding from 1 review